Differential pharmacological treatment of paraphilias and sex offenders

International Journal of Offender Therapy and Comparative Criminology

Volumn 47, Issue 4, 2003, Pages 407-421

  Hill, Andreas ^a   Briken, Peer ^a   Kraus, Christian ^a   Strohm, Kerstin ^a   Berner, Wolfgang ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CPA; LHRH agonist; Paraphilia; Pharmacotherapy; Sex offender; SSR1

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CITALOPRAM; CLOMIPRAMINE; CYPROTERONE ACETATE; FLUOXETINE; FLUVOXAMINE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE; NAFARELIN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TESTOSTERONE; TESTOSTERONE ENANTATE; TRIPTORELIN; VITAMIN D;

ADULT; AGED; ALGORITHM; ANEMIA; ANXIETY DISORDER; APPETITE DISORDER; CARDIOVASCULAR DISEASE; CHILD SEXUAL ABUSE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRY SKIN; DYSPEPSIA; ERECTILE DYSFUNCTION; EXHIBITIONISM; FATIGUE; FETISHISM; GALLSTONE; GYNECOMASTIA; HAIR LOSS; HEADACHE; HOMICIDE; HOT FLUSH; HUMAN; HYPOGONADISM; HYPONATREMIA; HYPOPITUITARISM; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY DYSFUNCTION; MALAISE; MALE; MASOCHISM; MUSCLE CRAMP; MUSCLE WEAKNESS; NAUSEA; NIGHTMARE; OFFENDER; OSTEOPOROSIS; PAIN; PEDOPHILIA; RAPE; RESTLESSNESS; SADISM; SEXUAL CRIME; SEXUAL DEVIATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SWEATING; THROMBOEMBOLISM; TOXIC HEPATITIS; VOMITING; WEIGHT GAIN;

ANDROGEN ANTAGONISTS; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PARAPHILIAS; SEROTONIN UPTAKE INHIBITORS; SEX OFFENSES; TREATMENT OUTCOME;

EID: 0043172225     PISSN: 0306624X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0306624X03253847     Document Type: Article

References (63)

1. Archer, J. (1991). The influence of testosterone on human aggression. Br J Psycho 782, 1-28
2. Bain, J., Langevin, R., Hucker, S., Dickey, R., Wright, P., & Schonberg, C. (1988). Sex hormones in pedophiles: I. baseline values of six hormones; II. the gonadotropin releasing hormone test. Ann Sex Res, 1, 443-454
3. Berger, P., Berner, W., Bolterauer, J., Gutierrez, K., & Berger, K. (1999). Sadistic personality disorder in sex-offenders. J Person Disorder, 13, 175-186
4. Berner, W., & Karlick-Bolten, E. (1986). Verlaufsformen der Sexualkriminalität [Development of sex offenders]. Stuttgart, Germany: Ferdinand Enke-Verlag
5. Blocher, D., Henkel, K., Retz, W., Retz-Junginger, P., Thome, J., & Rösler, M. (2001). Symptome aus dem Spektrum des hyperkinetischen Syndroms bei Sexualdelinquenten [Symptoms of the spectrum of hyperkinetic syndrome in sexual delinquents]. Forschr Neurol Psychiat, 69, 453-459
6. Boer, D. P., Hart, S. D., Kropp, P. R., & Webster, C. D. (1997). Manual for the sexual violence risk - 20. Burnaby, British Columbia, Canada: Mental Health, Law, and Policy Institute, Simon Fraser University
7. Bradford, J. M. W. (2000). The treatment of sexual deviation using a pharmacological approach. J Sex Res, 37, 248-257
8. Bradford, J. M. W. (2001). The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior. Can J Psychiatry, 46, 26-33
9. Bradford, J. M. W., & Greenberg, D. M. (1996). Pharmacological treatment of deviant sexual behavior. Ann Rev Sex Res, 7, 283-306
10. Bradford, J. M. W., & Pawlak, A. (1993). Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav, 22, 383-402
11. Briken, P. (2002). Pharmacotherapy of paraphilia with luteinizing hormone-releasing hormone agonists. Arch Gen Psych, 59, 469-470
12. Briken, P., Hill, A., & Berner, W. (2003). Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone releasing hormone (LHRH) - a systematic review. J Clin Psychiat
13. Briken, P., Nika, E., & Berner, W. (2001). Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther, 27, 45-55
14. Brown, S. L., Botsis, A., & van Praag, H. M. (1994). Serotonin and aggression. In M. Hillbrand, & N. J. Pallone (Eds.), The psychobiology of aggression (pp. 27-39). New York: Haworth
15. Coleman, E., Cesnik, J., Moore, A. M., & Dwyer, S. M. (1992). An exploratory study of the role of psychotropic medications in treatment of sexual offenders. J Offender Rehabil, 18, 75-88
16. Coleman, E., Gratzer, T., Nesvacil, L., & Raymond, N. C. (2000). Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: A retrospective study. J Clin Psychiat, 61, 282-284
17. Conn, M. P., & Crowley, W. F. (1991). Gonadotropin releasing hormone and its analogues. New England Journal of Medicine, 324, 93-103
18. Czerny, J. P., Briken, P., & Berner, W. (2002). Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Europ Psych, 17, 104-106
19. Ehrenkranz, J., Bliss, E., & Sheard, M. H. (1974). Plasmatestosterone: Correlation with aggressive behavior and social dominance in man. Psychosom Med, 36, 469-475
20. Furby, L., Weinrott, M.R., & Blackshaw, L. (1989). Sex offender recidivism: a review. Psychological Bulletin, 105, 3-30
21. Gaffney, G. R., & Berlin, F. S. (1984). Is there a hypothalamic-pituitary-gonadal dysfunction in paedophilia? A pilot study. Brit J Psychiat, 145, 657-660
22. Gijs, I., & Gooren, L. (1996). Hormonal and psychopharmacological interventions in the treatment of paraphilias: An update. J Sex Res, 33, 273-290
23. Grasswick, L. J., & Bradford, J. B. (2002, September). Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports. Paper presented at the seventh conference of the International Association for the Treatment of Sexual Offenders in Vienna, Austria. Forensische Psychiatrie und Psychotherapie (Suppl.), 9, 40
24. Greenberg, D. M., & Bradford, J. M. W. (1997). Treatment of the paraphilia disorders. A review of the role of selective serotonin reuptake inhibitors. Sexual Abuse, 9, 349-361
25. Greenberg, D. M., Bradford, J. M. W., Curry, S., & O’Rourke, A. B. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors. A retrospective study. Bull Am Acad Psychiat & Law, 24, 525-532
26. Hall, G. C. N. (1995). Sexual offender recidivism revisited. A meta-analysis of recent treatment studies. J Consult Clin Psychol, 63, 802-809
27. Hansen, H. (1991). Treatment of dangerous sexual offenders. In Seminar on Prison Health Services in Tampere, Finland (pp. 33-38). Helsinki, Finland: Ministry of Justice, Government Printing Centre
28. Hansen, H., & Lykke-Olesen, L. (1997). Treatment of dangerous sexual offender in Denmark. J Forensic Psychiat, 8, 195-199
29. Hanson, R. K., & Bussiere, M. T. (1998). Predicting relapse: A meta-analysis of sexual offender recidivism studies. J Consult Clin Psychol, 66, 348-362
30. Hanson, R. K., & Thornton, D. (2000). Static-99: Improving actuarial risk assessments for sex offenders. Ottawa: Department of the Solicitor General of Canada
31. Hare, R. D. (1991). Manual for the Hare Psychopathy Checklist-Revised. Toronto, Canada: Multi Health Systems
32. Higley, J. D., Mehlmann, P. T., Poland, R. E., Taub, D. M., Vickers, J., Suomi, S. J., et al. (1996). CSF testosterone and 5-HIAA correlate with different types of aggressive behavior. Biol Psychiat, 40, 1067-1082
33. Jannini, E. A., Screponi, E., Carosa, E., Pepe, M., Lo Giudice, F., Trimarchi, F., et al. (1999). Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl, 22, 385-392
34. Kafka, M. P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders. An open trial. Ann Clin Psychiat, 6, 189-195
35. Kafka, M. P. (2000). Psychopharmacological treatment for nonparaphilic compulsive sexual behavior. CNS Spectrums, 5, 49-59
36. Kafka, M. P., & Prentky, R. A. (1992). Fluoxetine-treatment of nonparaphilic sexual addictions and paraphilias in men. J Consult Clin Psychol, 53, 351-358
37. Kraus, C., Berner, W., & Nigbur, A. (1999). Bezüge der Psychopathy Checklist-Revised (PCL-R) zu den DSM-II-R und ICD-10-Klassifikationen bei Sexualstraftätern [Relations between the Psychopathy Checklist-Revised (PCL-R) and the DSM-III-R and JCD-10 classifications in sexual offenders]. Mschr Krim, 82(1), 36-46
38. Kreuz, L. E., & Rose, R. M. (1972). Assessment of aggressive behavior and plasma testosterone in a young criminal population. Psychosom Med, 34, 321-332
39. Krueger, R. B., & Kaplan, M. S. (2001). Depot-leuprolide acetate for treatment of paraphilias. A report of twelve cases. Arch Sex Behav, 30, 409-422
40. Langelüddeke, A. (1963). Die Entmannung von Sittlichkeitsverbrechern [The castration of sex offenders]. Berlin, Germany: De Gruyter
41. Laschet, U., & Laschet, L. (1971). Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 4, 99-104
42. Lidberg, L., Tuck, J. R., Asberg, M., Scalia-Tomba, G. P., & Bertilsson, L. (1985). Homicide, suicide and CSF 5-HIAA. Acta Physiol Scand, 71, 230-236
43. Maes, M., van West, D., De Vos, N., Westenberg, H., Van Hunsel, F., Hendriks, D., et al. (2001). Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia. Neuropsychopharmacology, 24, 37-46
44. McElroy, S. L., Soutullo, C. A., Taylor, P., Nelson, E. B., Beckman, D. A., Brusman, L. A., et al. (1999). Psychiatric features of 36 men convicted of sexual offenses. J Clin Psychiat, 60, 414-420
45. Mendels, J., Camera, A., & Sikes, C. (1995). Sertraline treatment for premature ejaculation. J Clin Psychopharm, 15, 341-346
46. Meston, C. M., & Frohlich, P. F. (2000). The neurobiology of sexual function. Arch Gen Psychiat, 57, 1012-1030
47. Reilly, D. R., Delva, N. J., & Hudson, R. W. (2000). Protocols of the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiat, 45, 559-563
48. Rösler, A., & Witztum, E. (1998). Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. New England Journal of Medicine, 338, 416-422
49. Rösler, A., & Witztum, E. (2000). Pharmacotherapy of the paraphilias in the next millennium. Behav Sci Law, 18, 43-56
50. Rubinow, D. R., & Schmidt, P. J. (1996). Androgens, brain and behavior. Am J Psychiat, 153, 974-984
51. Seim, H. C., & Dwyer, M. (1988). Evaluation of serum testosterone and luteinizing hormone levels in sex offenders. Fam Pract Res J, 7, 175-180
52. Simon, N. G., Cologer-Clifford, A., Lu, S. F., McKenna, S. E., & Hu, S. (1998). Testosterone and its metabolites modulate 5HT1A and 5HT1B agonist effects on intermale aggression. Neurosci Biobehav R, 23, 325-336
53. Smith, A. D., & Taylor, P. J. (1999). Serious sex offending against women by men with schizophrenia. Brit d Psychiat, 174, 233-237
54. Stein, D. J., Hollander, E., Anthony, D. T., Schneider, F. R., Fallon, B. A., Leibowitz, M. R., et al. (1992). Serotonergic medications for sexual obsessions, sexual addiction and paraphilias. J Clin Psychiat, 53, 267-271
55. Strohm, K., & Berner, W. (2001, October). Retrospektive Untersuchung zur Behandlung von paraphilen Störungen mit SSR1 [Retrospective study of the treatment of paraphilic disorders with SSRI]. Paper presented at the Münchner Herbsttagung für Forensische Psychiatrie, Munich, Germany
56. Stürup, G. K. (1972). Castration. The total treatment. In H. L. P. Resnik & M. E. Wolfgang (Eds.), Sexual behaviors. Social, clinical and legal aspects (pp. 361-382). Boston: Little, Brown
57. Thibaut, F., Cordier, B., & Kuhn, J. M. (1993). Effect of a long-lasting gonadotropin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiat Scand, 87, 445-450
58. Vaih-Koch, S. R., Ponseti, J., & Bosinski, H. A. G. (2001). ADHD und Störung des Sozialverhaltens im Kindesalter als Prädiktoren aggressiver Sexualdelinquenz? [ADHD and conduct disorder during childhood and predictors of sexual delinquency?]. Sexuologie, 8, 1-18
59. Virkkunen, M., Dejong, J., Bartko, J., & Linnoila, M. (1989). Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study. Arch Gen Psychiat, 46, 600-603
60. Virkkunen, M., Rawliongs, R., Tokola, R., Poland, R. E., Guidotti, A., Nemeroff, C., et al. (1994). CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiat, 51, 20-27
61. Volavka, J. (1995). Neurobiology of violence. Washington, DC: American Psychiatric Press
62. Waldinger, M. D., Berendsen, H. H., Blok, B. F., Olivier, B., & Holstege, G. (1998). Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation. The involvement of the serotonergic system. Behav Brain Res, 92, 111-118
63. Wille, R., & Beier, K. M. (1989). Castration in Germany. Ann Sex Res, 2, 103-133